Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database
Authors
Keywords
-
Journal
PROSTATE CANCER AND PROSTATIC DISEASES
Volume 16, Issue 4, Pages 391-397
Publisher
Springer Nature
Online
2013-10-08
DOI
10.1038/pcan.2013.48
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database
- (2013) Chenwei Wu et al. BJU INTERNATIONAL
- Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies
- (2012) Fan Zhang et al. ACTA DIABETOLOGICA
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality
- (2012) Daniel E. Spratt et al. EUROPEAN UROLOGY
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
- (2011) L. Azoulay et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
- (2011) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database
- (2011) B M Whitley et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Glycemic control and prostate cancer progression: Results from the SEARCH database
- (2010) Howard S. Kim et al. PROSTATE
- Clinical Outcomes After Radical Prostatectomy in Diabetic Patients Treated With Metformin
- (2010) Trushar Patel et al. UROLOGY
- Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
- (2009) Jonathan L. Wright et al. CANCER CAUSES & CONTROL
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study
- (2008) T. J. Murtola et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
- (2008) M. Zakikhani et al. Cancer Prevention Research
- Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
- (2008) Jocelyn S. Kasper et al. INTERNATIONAL JOURNAL OF CANCER
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
- (2008) Jing Ma et al. LANCET ONCOLOGY
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search